Kewaunee Scientific (KEQU) Cost of Revenue (2010 - 2026)

Kewaunee Scientific's Cost of Revenue history runs 17 years deep, the most recent figure standing at $50.2 million for Q2 2026.

• In Q2 2026, Cost of Revenue fell 5.56% year-over-year to $50.2 million; the TTM figure through Apr 2026 stood at $201.6 million (up 17.45% YoY), while the FY2026 annual figure was $201.6 million, up 17.45% from the prior year.
• Cost of Revenue for Q2 2026 stood at $50.2 million, down from $50.9 million in the prior quarter.
• The five-year high for Cost of Revenue was $53.1 million in Q2 2025, with the low at $33.8 million in Q4 2024.
• The 5-year median for Cost of Revenue is $43.8 million (2022), against an average of $43.6 million.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue plunged 31.18% in 2024, then soared 48.99% in 2025.
• Kewaunee Scientific's Cost of Revenue stood at $45.9 million in 2022, then slipped by 19.39% to $37.0 million in 2023, then dropped by 8.54% to $33.8 million in 2024, then jumped by 48.99% to $50.4 million in 2025, then dropped by 0.44% to $50.2 million in 2026.
• Business Quant data shows KEQU's Cost of Revenue at $50.2 million in Q2 2026, $50.9 million in Q1 2026, and $50.4 million in Q4 2025.